But now, an Indian company has delivered a promising innovative anti-cancer drug molecule to deep-pocketed Big Pharma for ...

A 200% tariff rate — even with a delay — will have a detrimental effect on drug prices and profit margins, analysts warn.

India's 500+ pharma GCCs signal paradigm shift in global drug discovery landscape: Nandita Vijayasimha, Bengaluru Monday, July 14, 2025, 08:00 Hrs [IST] India is using its technol ...

How fragmented savings undermine transparency, patient savings, and the pharma ecosystem. Drug discount programs can come in different forms, offering patients, healthcare providers, and manufacturers ...

Trump's NIH cuts are gutting university labs that fuel Big Pharma's drug pipeline and pushing U.S. biotech jobs, research, and investment overseas.

While Vietnam’s pharmaceutical manufacturers may face limited immediate exposure to the recent shifts in US drug pricing ...

Telangana State’s pharma future hinges on strategic collaboration between industry, academia & government: KV Rambabu: ...

Delray Beach, FL, June 16, 2025 (GLOBE NEWSWIRE) -- The global empty capsules market is entering a pivotal phase-set to grow from <b> US$3.1 billion ...

President Trump has threatened aggressive tariffs, potentially reaching 200%, on pharmaceutical imports, creating concerns ...

India's pharmaceutical market for FY 2023-24 is valued at $50 billion with domestic consumption valued at $23.5 billion and ...